ArticleCell reports. Medicine2022

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia.

Deepali Pal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.